Lenalidomide and Gemcitabine (Dose level 11)
T1421
Phase 2 small_molecule terminated
Quick answer
Lenalidomide and Gemcitabine (Dose level 11) for Peripheral T-cell Lymphomas (PTCL) is a Phase 2 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Peripheral T-cell Lymphomas (PTCL)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated